MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 7.582
EU - Europa 5.855
AS - Asia 4.584
SA - Sud America 716
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 18.814
Nazione #
US - Stati Uniti d'America 7.440
SG - Singapore 2.106
UA - Ucraina 1.133
IE - Irlanda 1.059
SE - Svezia 862
CN - Cina 714
HK - Hong Kong 697
IT - Italia 629
BR - Brasile 611
RU - Federazione Russa 567
DE - Germania 499
VN - Vietnam 449
FI - Finlandia 416
KR - Corea 292
GB - Regno Unito 244
FR - Francia 95
CA - Canada 77
BE - Belgio 60
TR - Turchia 55
IN - India 53
PL - Polonia 51
AR - Argentina 46
MX - Messico 43
AT - Austria 42
NL - Olanda 41
CZ - Repubblica Ceca 37
ZA - Sudafrica 34
JP - Giappone 33
UZ - Uzbekistan 33
BD - Bangladesh 29
IQ - Iraq 29
CH - Svizzera 28
EC - Ecuador 17
GR - Grecia 16
LT - Lituania 16
RO - Romania 16
CO - Colombia 15
ES - Italia 15
PK - Pakistan 11
ID - Indonesia 9
IL - Israele 9
LB - Libano 8
EU - Europa 7
VE - Venezuela 7
BG - Bulgaria 6
JO - Giordania 6
AZ - Azerbaigian 5
BO - Bolivia 5
CL - Cile 5
DZ - Algeria 5
JM - Giamaica 5
MA - Marocco 5
OM - Oman 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
KE - Kenya 4
KZ - Kazakistan 4
PT - Portogallo 4
SA - Arabia Saudita 4
AM - Armenia 3
AU - Australia 3
EG - Egitto 3
HR - Croazia 3
KG - Kirghizistan 3
MY - Malesia 3
PH - Filippine 3
PS - Palestinian Territory 3
TJ - Tagikistan 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
Totale 18.801
Città #
Singapore 1.419
Chandler 1.232
Dublin 1.059
Hong Kong 694
San Mateo 670
Jacksonville 634
Ashburn 421
Boardman 396
Ann Arbor 304
Seoul 287
Santa Clara 279
Medford 226
Princeton 224
Dong Ket 215
Beijing 203
Altamura 191
Perugia 171
Wilmington 164
Andover 161
Moscow 160
Munich 154
Lawrence 140
Los Angeles 124
New York 118
Piscataway 117
Helsinki 111
Turku 81
Ho Chi Minh City 79
Woodbridge 63
Saint Petersburg 62
Brussels 57
Norwalk 53
São Paulo 49
Hanoi 45
Shanghai 45
Houston 44
Des Moines 40
The Dalles 39
London 38
Dearborn 34
Brooklyn 33
Izmir 32
San Paolo di Civitate 32
Tokyo 32
Stockholm 31
Warsaw 30
Frankfurt am Main 28
Montreal 27
Auburn Hills 26
Dallas 26
Falkenstein 26
Orem 26
Council Bluffs 24
Johannesburg 24
Phoenix 24
Brno 23
Denver 22
Atlanta 21
Chicago 20
Redwood City 20
Rio de Janeiro 20
Amsterdam 19
San Francisco 19
San Jose 19
Bologna 17
Foligno 17
Boston 16
Nuremberg 16
Belo Horizonte 15
Milan 15
San Diego 15
Chennai 14
Hefei 14
Guangzhou 13
Mexico City 13
Poplar 13
Rome 13
Espoo 12
Falls Church 12
Redmond 12
Brasília 11
Charlotte 11
Manchester 11
Toronto 11
Baghdad 10
Da Nang 10
Florence 10
Quito 10
Tashkent 10
Vienna 10
Ankara 9
Campinas 9
Changsha 9
Groningen 9
Bucharest 8
Guarulhos 8
Haiphong 8
Ottawa 8
Seattle 8
West Jordan 8
Totale 11.622
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 163
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 157
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 153
Innate immunity against hematological malignancies 138
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 136
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 134
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 132
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 130
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 130
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 127
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 125
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 122
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 122
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 120
Acute lymphoblastic leukaemia in Noonan syndrome 120
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 118
Graft engineering for allogeneic haploidentical stem cell transplantation 116
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 116
Mesenchymal cells: a vehicle for gene therapy 112
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 112
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 111
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 111
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 111
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 109
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 109
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 108
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 108
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 107
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 107
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 107
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 106
5q- syndrome in a patient with chronic exposure to ionizing radiation. 105
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 104
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 104
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 104
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 103
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 101
"Designed" grafts for HLA-haploidentical stem cell transplantation. 101
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 101
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 100
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 100
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 100
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 99
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 99
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 98
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 97
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 96
Transplants across human leukocyte antigen barriers 96
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 96
Decreased bone mineral density after autologous stem cell transplantation. 96
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 96
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 96
T regulatory cell separation for clinical application. 96
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 96
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 95
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 95
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 95
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 94
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 93
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 93
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 93
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 93
Allogeneic transplantation across the HLA barriers. 93
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 92
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 92
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 92
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 92
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 92
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 91
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 91
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 91
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 91
Haploidentical stem cell transplantation for acute leukemia 90
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 90
Natural killer cell alloreactivity for leukemia therapy. 90
. Mismatched hematopoietic stem cell transplants in elderly patients. 90
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 89
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 89
Cellular therapy: exploiting NK cell alloreactivity in transplantation 88
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 88
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 88
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 88
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 88
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 88
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 88
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 88
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 87
Submicroscopic deletions in 5q- associated malignancies 86
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 85
Different genomic imbalances in low- and high-grade HCV-related lymphomas 85
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 85
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 85
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 85
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 85
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 85
Mismatched hematopoietic stem cell transplantation in secondary leukemia 84
Quantitative detection of NPM1 mutations as marker of minimal residual disease (MRD) in the large majority of AML with normal karyotype 84
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 84
Totale 10.210
Categoria #
all - tutte 84.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.166 0 0 0 0 0 142 198 12 249 91 220 254
2021/20222.169 55 525 71 175 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20253.333 93 347 136 156 446 146 91 253 620 185 567 293
2025/20264.080 537 477 338 975 1.061 692 0 0 0 0 0 0
Totale 19.286